lightox.co.uk valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
# This space intentionally left blank # If you want to learn about why our robots.txt looks like this, read this post: https://yoa.st/robots-txt User-agent:
Meta Tags
Title HOME -
Description Light activated chemotherapy for treatment of early-stage mouth Illuminating therapeutics & research tools. LightOx are developing new therapeutic solutions to improve patient’s function and long-term outcomes with oral cancer. We have a unique range of molecular tools for use in imaging, therapeutics and assay
Keywords N/A
Server Information
WebSite lightox faviconlightox.co.uk
Host IP 192.124.249.167
Location -
Related Websites
Site Rank
More to Explore
lightox.co.uk Valuation
US$1,781,077
Last updated: 2023-05-17 09:54:19

lightox.co.uk has Semrush global rank of 5,942,644. lightox.co.uk has an estimated worth of US$ 1,781,077, based on its estimated Ads revenue. lightox.co.uk receives approximately 205,509 unique visitors each day. Its web server is located in -, with IP address 192.124.249.167. According to SiteAdvisor, lightox.co.uk is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,781,077
Daily Ads Revenue US$1,645
Monthly Ads Revenue US$49,323
Yearly Ads Revenue US$591,866
Daily Unique Visitors 13,701
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
lightox.co.uk. A 3600 IP: 192.124.249.167
lightox.co.uk. NS 3600 NS Record: ns75.domaincontrol.com.
lightox.co.uk. NS 3600 NS Record: ns76.domaincontrol.com.
lightox.co.uk. MX 3600 MX Record: 0 lightox-co-uk.mail.protection.outlook.com.
lightox.co.uk. TXT 1800 TXT Record: v=verifydomain MS=9389674
lightox.co.uk. TXT 1800 TXT Record: v=spf1 ip4:31.170.121.235 include:spf.protection.outlook.com -all
lightox.co.uk. TXT 1800 TXT Record: google-site-verification=BFyeioBx9-412IkDk6hNiBfnv8F7g2KxMlyWN26oPhM
lightox.co.uk. TXT 1800 TXT Record: google-site-verification=uDqiVZZqqZHH2Cw6XJSz5g3OFIVBUruL9zGb75LTTaA
HtmlToTextCheckTime:2023-05-17 09:54:19
Home Therapeutics Pipeline LXD191 About News & Events Contact Light activated chemotherapy for treatment of early-stage mouth cancers. Developing new therapeutic solutions to improve patient function and long-term outcomes. LEARN MORE OVERVIEW LightOx is headquartered in Newcastle upon Tyne, UK and is developing new light activated drug compounds. We are targeting a treatment for early stage and pre-cancerous lesions and are currently completing pre-clinical testing. Our lead candidate will enter Phase I/2a study for the treatment of early-stage oral cancer lesions in 2022 with our clinical team in Liverpool, UK. With an IP portfolio consisting of five global patents, and a vibrant team experienced novel therapeutics, LightOx has a solid scientific and commercial base and looks to develop a range of treatments from its platform technology. We are exploring projects and applications that spread beyond oncology targets, with the technology demonstrated in bacterial, fungal and plant
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: Sucuri/Cloudproxy
Date: Sat, 19 Mar 2022 08:40:17 GMT
Content-Type: text/html; charset=iso-8859-1
Content-Length: 230
Connection: keep-alive
X-Sucuri-ID: 15017
X-XSS-Protection: 1; mode=block
X-Frame-Options: SAMEORIGIN
X-Content-Type-Options: nosniff
Location: https://lightox.co.uk/
X-Sucuri-Cache: EXPIRED

HTTP/2 200 
server: nginx
date: Sat, 19 Mar 2022 08:40:18 GMT
content-type: text/html; charset=UTF-8
x-sucuri-id: 15017
x-xss-protection: 1; mode=block
x-frame-options: SAMEORIGIN
x-content-type-options: nosniff
content-security-policy: upgrade-insecure-requests;
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
x-sucuri-cache: EXPIRED

Copyright © 2022 WebZZ.US 0.0298